The store will not work correctly when cookies are disabled.
5-(2-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA80963
PubChem CID: 10378954
Max Phase: Preclinical
Molecular Formula: C17H13ClN2
Molecular Weight: 280.76
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccccc1C1=Cc2ccccc2C2=NCCN12
Standard InChI: InChI=1S/C17H13ClN2/c18-15-8-4-3-7-14(15)16-11-12-5-1-2-6-13(12)17-19-9-10-20(16)17/h1-8,11H,9-10H2
Standard InChI Key: ZMIKNFPFDYACPD-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
2.7667 -2.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7375 -3.3000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2250 -3.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2542 -2.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3667 -2.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7042 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2250 -4.2042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7250 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6667 -3.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 -3.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 -4.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6625 -3.8292 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.6625 -2.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1750 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2125 -2.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2667 -3.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2542 -2.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6625 -3.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6792 -2.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5625 -2.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 1 1 0
6 8 2 0
7 3 2 0
8 4 1 0
9 5 2 0
10 2 1 0
11 10 1 0
12 9 1 0
13 5 1 0
14 6 1 0
15 8 1 0
16 9 1 0
17 13 2 0
18 19 1 0
19 15 2 0
20 17 1 0
3 6 1 0
7 11 1 0
16 20 2 0
18 14 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.76 | Molecular Weight (Monoisotopic): 280.0767 | AlogP: 3.91 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.90 | CX LogP: 3.66 | CX LogD: 3.55 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -0.37 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |